Cargando…

A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis

Increased concentrations of interleukin (IL)-1α have been recently described in tissues of patients with systemic sclerosis (SSc) suggesting that IL-1α inhibition may be a target for treatment. We conducted a double-blind, placebo-controlled study to assess the safety and efficacy of the fully human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solomonidi, Nicky, Vlachoyiannopoulos, Panayiotis G., Pappa, Maria, Liantinioti, Georgia, Ktena, Sofia, Theotikos, Evangelos, Elezoglou, Antonia, Netea, Mihai G., Giamarellos-Bourboulis, Evangelos J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481358/ https://www.ncbi.nlm.nih.gov/pubmed/37680472 http://dx.doi.org/10.1016/j.isci.2023.107670

Ejemplares similares

The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
por: Theotikos, Evangelos, et al.
Publicado: (2017)

Spontaneous Chalk-Stick Fracture in Ankylosing Spondylitis: A Case Report
por: Katsimpari, Chaido, et al.
Publicado: (2022)

Pulmonary fibrosis and microscopic polyangiitis in a 75-year-old woman
por: Koutsoviti, Sofia, et al.
Publicado: (2019)

Septic Arthritis Complicating a Gout Flare: Report of Two Cases and Review of the Literature
por: Tzanis, Prokopios, et al.
Publicado: (2022)

Editorial Introduction to the Supplement “Diagnosis of Infectious Diseases by Detection of Microbial Pathogens: A Joint Session Between HemoSpec FrameWork 7 Consortium with COST Action BM1401 Raman4Clinics Working Group 2”
por: Giamarellos-Bourboulis, Evangelos J.
Publicado: (2018)

Association between genotypes of rs34436714 of NLRP12 and serum tumor necrosis factor-alpha in inflammatory bowel disease: A case-control study
por: Dellaporta, Erminia, et al.
Publicado: (2019)

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes
por: Keur, Nick, et al.
Publicado: (2023)

Periaortitis and diffuse subendocardial vasculitis in a patient with systemic lupus erythematosus – Lupus flare or a coexisting disease?
por: Gioti, Ourania, et al.
Publicado: (2019)

Complex immune deregulation in severe COVID-19: More than a mechanism of pathogenesis
por: Giamarellos-Bourboulis, Evangelos J.
Publicado: (2021)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
por: Nikoloudaki, Myrto, et al.
Publicado: (2023)

A 29-MRNA HOST RESPONSE WHOLE-BLOOD SIGNATURE IMPROVES PREDICTION OF 28-DAY MORTALITY AND 7-DAY INTENSIVE CARE UNIT CARE IN ADULTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH SUSPECTED ACUTE INFECTION AND/OR SEPSIS
por: Kostaki, Antigone, et al.
Publicado: (2022)

A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patients
por: Safarika, Asimina, et al.
Publicado: (2021)

Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
por: Karakike, Eleni, et al.
Publicado: (2021)

THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS
por: de Nooijer, Aline H., et al.
Publicado: (2023)

The complex pathogenesis of bacteremia: From antimicrobial clearance mechanisms to the genetic background of the host
por: Christaki, Eirini, et al.
Publicado: (2014)

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
por: Karakike, Eleni, et al.
Publicado: (2019)

Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2022)

Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
por: Netea, Mihai G., et al.
Publicado: (2020)

Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2020)

Staphylococcus Aureus Osteomyelitis as an Inducer of Tolerance to Escherichia Coli Pyelonephritis: an Experimental Study
por: Goumenos, Stavros, et al.
Publicado: (2020)

Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes
por: de Nooijer, Aline H, et al.
Publicado: (2020)

Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Obesity as a Consequence of Gut Bacteria and Diet Interactions
por: Kotzampassi, Katerina, et al.
Publicado: (2014)

Reply to Radermacher et al. on “Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus”
por: Renieris, Georgios, et al.
Publicado: (2021)

Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
por: Hayek, Salim S., et al.
Publicado: (2021)

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

BioFire(®) FilmArray(®) Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
por: Leventogiannis, Konstantinos, et al.
Publicado: (2022)

Compartmentalized Cytokine Responses in Hidradenitis Suppurativa
por: Kanni, Theodora, et al.
Publicado: (2015)

In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections
por: Pistiki, Aikaterini, et al.
Publicado: (2015)

Sepsis: Diagnostic and Therapeutic Challenges
por: Molnár, Zsolt, et al.
Publicado: (2016)

Monkeypox: A real new warning or just a sign of times?
por: Georgiadou, Sara P., et al.
Publicado: (2023)

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

Probiotics in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2023)

Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect
por: Mihailidou, Ira, et al.
Publicado: (2013)

An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial
por: Tsilika, Maria, et al.
Publicado: (2023)

IL-1 Mediates Tissue-Specific Inflammation and Severe Respiratory Failure in COVID-19
por: Renieris, Georgios, et al.
Publicado: (2022)

Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2016)

Small Intestine Bacterial Overgrowth Can Form an Indigenous Proinflammatory Environment in the Duodenum: A Prospective Study
por: Rizos, Evripidis, et al.
Publicado: (2022)

Single nucleotide polymorphisms of Toll-like receptor-4 and of autophagy-related gene 16 like-1 gene for predisposition of premature delivery: A prospective study
por: Liassides, Christakis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rggc6og25tajk8ntennnl2ncel